Karmanos Cancer Institute Hits Record Growth with 47% Patient Surge
Event summary
- Karmanos Cancer Institute treated 15,754 new cancer cases in FY2025, a 47% increase from 10,670 cases in 2020.
- The institute expanded its clinical space by nearly 128,000 square feet across Michigan since 2020.
- Karmanos opened 609 clinical trials and enrolled over 2,700 patients in interventional studies between 2020 and October 2025.
- The institute recruited 43 scientists and clinicians since 2020 to strengthen its research and treatment capabilities.
The big picture
Karmanos Cancer Institute's record growth reflects a strategic focus on expanding access, investing in cutting-edge research, and attracting top clinical talent. The institute's ability to integrate advanced therapies with compassionate care positions it as a leader in oncology care delivery, addressing both regional demand and national trends toward personalized medicine.
What we're watching
- Sustainable Growth
- Whether Karmanos can maintain its rapid growth trajectory while preserving quality and patient experience.
- Innovation Leadership
- How the institute's investments in advanced therapies and clinical trials will position it against competitors.
- Geographic Expansion
- The pace at which Karmanos can expand its reach beyond Michigan to attract more out-of-state and international patients.
Related topics